Skip to main content

Vaccines to prompt rapid growth in 2021 and 2022

Euro-zone GDP looks set to fall in Q4, but the prospect of vaccine rollouts has significantly improved the outlook. We think that containment measures will be scaled back when the most vulnerable members of society are inoculated, which will probably be during the second quarter of next year. This suggests that euro-zone GDP will rebound rapidly in Q2 and Q3 next year. We suspect that growth will then remain above trend until at least the end of 2022. Our new forecasts are stronger than the consensus and ECB projections. When the ECB updates its forecasts next week, we expect it to remain cautious about economic prospects, in part because it will want to reinforce its dovish message.

Become a client to read more

This is premium content that requires an active Capital Economics subscription to view.

Already have an account?

You may already have access to this premium content as part of a paid subscription.

Sign in to read the content in full or get details of how you can access it

Register for free

Sign up for a free account to gain:

  • Unlock additional content
  • Register for Capital Economics events
  • Receive email updates and economist-curated newsletters
  • Request a free trial of our services


Get access